XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 28, 2023
Oct. 29, 2022
Operating activities:    
Net (loss) income $ (15,530) $ 52,255
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation 14,138 15,793
Asset impairment 178  
Non-cash operating lease costs 38,494 38,474
Loss on disposal of property and equipment 23 10
Deferred income taxes (4,304) 2,119
Insurance proceeds related to operating activities 3,482 1,575
Non-cash stock-based compensation expense 3,002 2,271
Gain on sale-leaseback   (64,088)
Gain on insurance related to operating activities (3,482)  
Changes in assets and liabilities:    
Inventory (23,933) (5,891)
Prepaid and other current assets 1,711 1,734
Other assets 133 99
Accounts payable 2,322 (15,572)
Accrued expenses and other long-term liabilities (45,515) (44,643)
Accrued compensation (1,821) (15,216)
Income tax receivable/payable (2,691) 6,899
Layaway deposits 925 1,122
Net cash used in operating activities (32,868) (23,059)
Investing activities:    
Purchases of property and equipment (11,568) (19,218)
Insurance proceeds related to investing activities 1,518 1,370
Proceeds from sale-leaseback   81,098
Net cash (used in) provided by investing activities (10,050) 63,250
Financing activities:    
Cash used to settle withholding taxes on the vesting of nonvested restricted stock (851) (2,208)
Repurchases of common stock   (10,000)
Net cash used in financing activities (851) (12,208)
Net (decrease) increase in cash and cash equivalents (43,769) 27,983
Cash and cash equivalents:    
Beginning of period 103,495 49,788
End of period 59,726 77,771
Supplemental disclosures of cash flow information:    
Cash paid for interest 119 119
Cash payments of income taxes 1,545 6,606
Supplemental disclosures of non-cash investing activities:    
Accrual for purchases of property and equipment $ 841 $ 595